Article info

Download PDFPDF

Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden
Free
  1. Correspondence to:
    MrN Bansback
    Health Economics and Decision Science, ScHARR, University of Sheffield, Regent Court, 40 Regent Street, Sheffield S1 4DA UK; n.j.bansbacksheffield.ac.uk
View Full Text

Citation

Bansback NJ, Brennan A, Ghatnekar O
Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden

Publication history

  • Accepted November 9, 2004
  • First published November 18, 2004.
Online issue publication 
June 15, 2005

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.